LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)
Download: Excel (XLSX), Comma-separated (CSV)
| Small Molecule | barcode | cell_count | frac_dead | corpse_count | cell_count_dead | row | column | agent | concentration | role | timepoint | replicate | cell_line | dead_count | fraction_dead | cell_count__time0 | dead_count__time0 | cell_count__ctrl | dead_count__ctrl | fraction_dead__ctrl | increase_fraction_dead | GRvalue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dasatinib | 180614_BG_03 | 17365 | 0.0167 | 69 | 223 | 10 | 17 | Dasatinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_4 | 292 | 0.0165 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00346 | 1.0085 |
| Dasatinib | 180614_BG_03 | 16731 | 0.0154 | 57 | 202 | 10 | 18 | Dasatinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_5 | 259 | 0.0152 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00475 | 0.9910 |
| Dasatinib | 180614_BG_03 | 16023 | 0.0173 | 71 | 208 | 13 | 18 | Dasatinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_6 | 279 | 0.0171 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00288 | 0.9709 |
| Dasatinib | 180614_BG_04 | 15320 | 0.0287 | 170 | 275 | 6 | 19 | Dasatinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_7 | 445 | 0.0282 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00823 | 0.9503 |
| Dasatinib | 180614_BG_04 | 17045 | 0.0174 | 96 | 202 | 9 | 3 | Dasatinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_8 | 298 | 0.0172 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00281 | 0.9997 |
| Dasatinib | 180614_BG_04 | 16506 | 0.0206 | 110 | 233 | 11 | 19 | Dasatinib | 0.003326667 | treatment | 72 | 1 | MCF10A-GM_9 | 343 | 0.0204 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00036 | 0.9847 |
| Dasatinib | 180614_BG_02 | 17431 | 0.0166 | 32 | 258 | 9 | 14 | Dasatinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_1 | 290 | 0.0164 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00363 | 1.0103 |
| Dasatinib | 180614_BG_02 | 16726 | 0.0193 | 62 | 262 | 12 | 9 | Dasatinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_2 | 324 | 0.0190 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00099 | 0.9909 |
| Dasatinib | 180614_BG_02 | 15955 | 0.0207 | 50 | 281 | 13 | 3 | Dasatinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_3 | 331 | 0.0203 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00033 | 0.9690 |
| Dasatinib | 180614_BG_03 | 15615 | 0.0156 | 64 | 181 | 5 | 15 | Dasatinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_4 | 245 | 0.0154 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00455 | 0.9591 |
| Dasatinib | 180614_BG_03 | 15704 | 0.0164 | 52 | 206 | 8 | 20 | Dasatinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_5 | 258 | 0.0162 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00383 | 0.9617 |
| Dasatinib | 180614_BG_03 | 16537 | 0.0134 | 64 | 159 | 9 | 15 | Dasatinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_6 | 223 | 0.0133 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00669 | 0.9856 |
| Dasatinib | 180614_BG_04 | 16420 | 0.0246 | 164 | 244 | 7 | 12 | Dasatinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_7 | 408 | 0.0242 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00425 | 0.9823 |
| Dasatinib | 180614_BG_04 | 17068 | 0.0218 | 115 | 260 | 9 | 10 | Dasatinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_8 | 375 | 0.0215 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00150 | 1.0004 |
| Dasatinib | 180614_BG_04 | 16384 | 0.0227 | 153 | 222 | 9 | 11 | Dasatinib | 0.00998 | treatment | 72 | 1 | MCF10A-GM_9 | 375 | 0.0224 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00238 | 0.9813 |
| Dasatinib | 180614_BG_02 | 13937 | 0.0147 | 40 | 166 | 8 | 21 | Dasatinib | 0.033266667 | treatment | 72 | 1 | MCF10A-GM_1 | 206 | 0.0146 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00543 | 0.9075 |
| Dasatinib | 180614_BG_02 | 15269 | 0.0196 | 54 | 246 | 11 | 16 | Dasatinib | 0.033266667 | treatment | 72 | 1 | MCF10A-GM_2 | 300 | 0.0193 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00073 | 0.9488 |
| Dasatinib | 180614_BG_02 | 15638 | 0.0175 | 27 | 247 | 12 | 18 | Dasatinib | 0.033266667 | treatment | 72 | 1 | MCF10A-GM_3 | 274 | 0.0172 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00278 | 0.9597 |
| Dasatinib | 180614_BG_03 | 14348 | 0.0240 | 119 | 228 | 3 | 7 | Dasatinib | 0.033266667 | treatment | 72 | 1 | MCF10A-GM_4 | 347 | 0.0236 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00362 | 0.9205 |
| Dasatinib | 180614_BG_03 | 14962 | 0.0173 | 73 | 187 | 6 | 15 | Dasatinib | 0.033266667 | treatment | 72 | 1 | MCF10A-GM_5 | 260 | 0.0171 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00291 | 0.9395 |
| Dasatinib | 180614_BG_03 | 14695 | 0.0177 | 72 | 189 | 8 | 18 | Dasatinib | 0.033266667 | treatment | 72 | 1 | MCF10A-GM_6 | 261 | 0.0175 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00254 | 0.9313 |
| Dasatinib | 180614_BG_04 | 15338 | 0.0274 | 168 | 257 | 3 | 8 | Dasatinib | 0.033266667 | treatment | 72 | 1 | MCF10A-GM_7 | 425 | 0.0270 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00697 | 0.9508 |
| Dasatinib | 180614_BG_04 | 15301 | 0.0242 | 179 | 195 | 3 | 17 | Dasatinib | 0.033266667 | treatment | 72 | 1 | MCF10A-GM_8 | 374 | 0.0239 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00386 | 0.9497 |
| Dasatinib | 180614_BG_04 | 16850 | 0.0209 | 128 | 226 | 9 | 9 | Dasatinib | 0.033266667 | treatment | 72 | 1 | MCF10A-GM_9 | 354 | 0.0206 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00058 | 0.9944 |
| Dasatinib | 180614_BG_02 | 9659 | 0.0255 | 27 | 220 | 5 | 17 | Dasatinib | 0.099799999 | treatment | 72 | 1 | MCF10A-GM_1 | 247 | 0.0249 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00494 | 0.7502 |